官方服务：
资源简介：
AML mouse models
应用场景：
创建时间：
2011-08-04
相关数据集
Expression profile from murine acute myeloid leukemia cells C1498 with or without PARP-1 inhibition. Mus musculus
Poly(ADP-ribose) polymerase 1 (PARP-1) is abnormally expressed in a wide variety of tumors. Emerging evidence suggests that PARP-1 plays key roles in multiple biologic behaviors of tumors, such as mod
NIAID Data Ecosystem50
DataSheet_1_Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations.docx
Adult acute myeloid leukemia (AML) patients with biallelic mutations of CEBPA (biCEBPA) displays a favorable clinical outcome, and is defined as a unique entity in the 2016 World Health Organization c
NIAID Data Ecosystem30
Discovery of FLC‑8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia
FLT3 is a validated therapeutic target in acute myeloid leukemia (AML), yet resistance mutations frequently limit current inhibitors. Here, we report a series of 6-methylisoxazolo[5,4-b]pyridin-3-amin
NIAID Data Ecosystem20
Supplementary Table 2 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
Transcription Factor Enrichment Analysis of MOLM13 Bulk RNA-Seq (24 Hours After Drug Treatment)
Figshare2023-07-05 更新40
Supplementary Table 9 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
Differential Phosphoprotein Network Enrichment in MOLM13 Cells (24 Hours After Drug Treatment)
NIAID Data Ecosystem20
